123 related articles for article (PubMed ID: 6400065)
1. Induction of leukemia cell differentiation by chemotherapeutic agents.
Schwartz EL; Ishiguro K; Sartorelli AC
Adv Enzyme Regul; 1983; 21():3-20. PubMed ID: 6400065
[TBL] [Abstract][Full Text] [Related]
2. Alterations in tyrosine phosphorylation during the granulocytic maturation of HL-60 leukemia cells.
Frank DA; Sartorelli AC
Cancer Res; 1988 Jan; 48(1):52-8. PubMed ID: 2825968
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of the differentiation-inducing properties of 6-thioguanine by hypoxanthine and its nucleosides in HL-60 promyelocytic leukemia cells.
Ishiguro K; Sartorelli AC
Cancer Res; 1985 Jan; 45(1):91-5. PubMed ID: 3855287
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships for the induction of differentiation of HL-60 human acute promyelocytic leukemia cells by anthracyclines.
Schwartz EL; Sartorelli AC
Cancer Res; 1982 Jul; 42(7):2651-5. PubMed ID: 6952957
[TBL] [Abstract][Full Text] [Related]
5. The 1985 Walter Hubert lecture. Malignant cell differentiation as a potential therapeutic approach.
Sartorelli AC
Br J Cancer; 1985 Sep; 52(3):293-302. PubMed ID: 3899154
[TBL] [Abstract][Full Text] [Related]
6. Induction of erythroid differentiation by the anthracycline antitumor antibiotics, aclacinomycin A, musettamycin and marcellomycin.
Steinheider G; Westendorf J; Marquardt H
Leuk Res; 1986; 10(10):1233-9. PubMed ID: 3464812
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the metabolic forms of 6-thioguanine responsible for cytotoxicity and induction of differentiation of HL-60 acute promyelocytic leukemia cells.
Ishiguro K; Schwartz EL; Sartorelli AC
J Cell Physiol; 1984 Nov; 121(2):383-90. PubMed ID: 6593322
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of some anthracycline antibiotics in an in vivo model for studying drug-induced human leukemia cell differentiation.
Schwartz EL; Brown BJ; Nierenburg M; Marsh JC; Sartorelli AC
Cancer Res; 1983 Jun; 43(6):2725-30. PubMed ID: 6573951
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle events associated with the termination of proliferation by cytotoxic and differentiation-inducing actions of 6-thioguanine on HL-60 cells.
Schwartz EL; Blair OC; Sartorelli AC
Cancer Res; 1984 Sep; 44(9):3907-10. PubMed ID: 6589046
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of human promyelocytic leukemia cells in vitro by 6-thioguanine.
Papac RJ; Brown AE; Schwartz EL; Sartorelli AC
Cancer Lett; 1980 Jul; 10(1):33-8. PubMed ID: 6939481
[TBL] [Abstract][Full Text] [Related]
11. Characterization of differentiation-inducer-resistant HL-60 cells.
Gallagher RE; Bilello PA; Ferrari AC; Chang CS; Yen RW; Nickols WA; Muly EC
Leuk Res; 1985; 9(8):967-86. PubMed ID: 3862924
[TBL] [Abstract][Full Text] [Related]
12. Induction of erythroid differentiation by the anthracycline antitumor antibiotic pyrromycin.
Steinheider G; Schaefer A; Westendorf J; Marquardt H
Cell Biol Toxicol; 1988 Mar; 4(1):123-33. PubMed ID: 3228706
[TBL] [Abstract][Full Text] [Related]
13. Guanine analog-induced differentiation of human promyelocytic leukemia cells and changes in queuine modification of tRNA.
Kretz KA; Katze JR; Trewyn RW
Mol Cell Biol; 1987 Oct; 7(10):3613-9. PubMed ID: 3479681
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of glycoprotein biosynthesis by the inducers of HL-60 cell differentiation, aclacinomycin A and marcellomycin.
Morin MJ; Sartorelli AC
Cancer Res; 1984 Jul; 44(7):2807-12. PubMed ID: 6327026
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship between anthracycline-induced differentiation and inhibition of glycoprotein synthesis in Friend erythroleukemia cells.
Schaefer A; Dahle M; Radenz G; Steinheider G; Marquardt H
Leukemia; 1991 Feb; 5(2):95-100. PubMed ID: 2020200
[TBL] [Abstract][Full Text] [Related]
16. Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL-60) by componuds which induce differentiation of murine leukemia cells.
Collins SJ; Bodner A; Ting R; Gallo RC
Int J Cancer; 1980 Feb; 25(2):213-8. PubMed ID: 6156128
[TBL] [Abstract][Full Text] [Related]
17. 6-ethylmercaptopurine-mediated growth inhibition of HL-60 cells in vitro irrespective of purine salvage.
Gibboney DS; French BT; Patrick DE; Trewyn RW
Cancer Chemother Pharmacol; 1989; 25(3):189-94. PubMed ID: 2598410
[TBL] [Abstract][Full Text] [Related]
18. Modulation of thiopurine cytotoxicity in the HL-60 cell line by physiological concentrations of hypoxanthine.
Zimm S; Johnson GE; Poplack DG
Cancer Res; 1986 Dec; 46(12 Pt 1):6286-9. PubMed ID: 3465436
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms involved in the induction of malignant cell differentiation.
Sartorelli AC; Ishiguro K; King CL; Morin MJ; Reiss M
Adv Enzyme Regul; 1986; 25():507-29. PubMed ID: 3544708
[TBL] [Abstract][Full Text] [Related]
20. Induction of erythroid differentiation in vitro by purines and purine analogues.
Gusella JF; Housman D
Cell; 1976 Jun; 8(2):263-9. PubMed ID: 971485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]